Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

1-(1H-Benzimidazol-2-yl)-4-nitro-benzene dimethyl-formamide solvate.

ABSTRACT: In the title compound, C(13)H(9)N(3)O(2)·C(3)H(7)NO, the benzimidazole ring system and the benzene ring are essentially coplanar, forming a dihedral angle of 0.86?(5)°. The crystal packing is stabilized by an inter-molecular N-H?O hydrogen bond and a ?-? stacking inter-action with a centroid-centroid separation of 3.685?(4)?Å.

SUBMITTER: Wu DH

PROVIDER: S-EPMC2968547 | biostudies-literature | 2009 Feb

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

1-(1H-Benzimidazol-2-yl)-4-nitro-benzene dimethyl-formamide solvate.

Wu De-Hong DH

Acta crystallographica. Section E, Structure reports online 20090221 Pt 3

In the title compound, C(13)H(9)N(3)O(2)·C(3)H(7)NO, the benzimidazole ring system and the benzene ring are essentially coplanar, forming a dihedral angle of 0.86 (5)°. The crystal packing is stabilized by an inter-molecular N-H⋯O hydrogen bond and a π-π stacking inter-action with a centroid-centroid separation of 3.685 (4) Å. ...[more]

PMID: 21582215

Similar Datasets

(Dimethyl-formamide)(2-methyl-propen-oato)[tris-(1-methyl-1H-benzimidazol-2-ylmeth-yl)amine]-manganese(II) perchlorate dimethyl-formamide solvate.

Project description:In the title complex, [Mn(C(4)H(5)O(2))(C(27)H(27)N(7))(C(3)H(7)NO)]ClO(4)·C(3)H(7)NO, the Mn(II) ion is seven-coordinated in a distorted monocapped trigonal-prismatic geometry formed by a tetra-dentate tris-(1-methyl-1H-benzimidazol-2-ylmeth-yl)amine mol-ecule, a bidentate 2-methacrylate anion and a dimethyl-formamide mol-ecule. The methyl groups of the coordinated dimethyl-formamide mol-ecule and the perchlorate anions are disordered over two positions with occupancy factors of 0.640 (8) and 0.360 (8).

| S-EPMC2983334 | biostudies-literature

1,4-Bis(benzimidazol-2-yl)benzene dimethyl-formamide disolvate.

Project description:The aromatic mol-ecule of the title compound, C(20)H(14)N(4)·2C(3)H(7)NO, occupies a special position on an inversion center. The benzimidazole unit (planar to within 0.008?Å) forms a dihedral angle of 9.1?(2)° with the central benzene ring. The benzimidazole H atom participates in a hydrogen bond with the dimethyl-formamide solvent molecule, thus giving rise to the title 1:2 aggregate. These aggregates are further linked in the crystal structure by aromatic ?-? stacking inter-actions [centroid-centroid distance = 6.356?(2)?Å].

| S-EPMC2968526 | biostudies-literature

4-Chloro-2-(6-nitro-1H-benzimidazol-2-yl)phenol N,N-dimethyl-form-amide solvate.

Project description:In the title compound, C(13)H(8)ClN(3)O(3)·C(3)H(7)NO, the benzimidazole and benzene rings make a dihedral angle of 0.63?(11)°. An intra-molecular O-H?N hydrogen bond generates an S(6) ring motif. The solvent mol-ecule is hydrogen-bonded to the benzimidazole mol-ecule by inter-molecular N-H?O and C-H?O hydrogen bonds, generating an R(1) (2)(7) ring motif. In the crystal, the mol-ecules are arranged into parallel layers perpendicular to the c axis and stabilized by weak ?-? inter-actions [centroid-centroid distances in the range 3.4036?(18)-3.5878?(16)?Å].

| S-EPMC3009370 | biostudies-literature

Bis[2,6-bis-(1H-benzimidazol-2-yl)pyridine]-nickel(II) dipicrate dimethyl-formamide disolvate.

Project description:In the title compound, [Ni(C(19)H(13)N(5))(2)](C(6)H(2)N(3)O(7))(2)·2C(3)H(7)NO, the Ni(II) ion is coordinated by two tridentate 2,6-bis-(1H-benzimidazol-2-yl)pyridine ligands in a distorted octa-hedral geometry. In the crystal structure, the picrate anions and solvent dimethyl-formamide (DMF) mol-ecules are connected to the cation via inter-molecular N-H⋯O hydrogen bonds. Further stabilization is provided by weak inter-molecular C-H⋯O hydrogen bonds. One of the DMF moleclues is disordered over two sites with refined occupancies of 0.737 (3) and 0.263 (3).

| S-EPMC3007574 | biostudies-literature

Bis{?-1,3-bis-[(benzimidazol-1-yl)meth-yl]benzene-?N:N}bis-[dichloridozinc(II)] dimethyl-formamide disolvate.

Project description:In the title compound, [Zn(2)Cl(4)(C(22)H(18)N(4))(2)]·2C(3)H(7)NO, the 1,3-bis-[(benzimidazol-1-yl)meth-yl]benzene ligand bridges two ZnCl(2) units, forming a centrosymmetric dinuclear mol-ecule. The Zn(II) atom shows a distorted tetra-hedral coordination within a Cl(2)N(2) donor set.

| S-EPMC2969561 | biostudies-literature

2-(1H-Benzimidazol-2-yl)-N-[(E)-(dimethyl-amino)-methyl-idene]benzene-sulfonamide.

Project description:The asymmetric unit of the title compound, C(16)H(16)N(4)O(2)S, contains two mol-ecules (A and B) with similar conformations: the benzene rings are oriented at dihedral angles of 80.94 (10)° and 84.54 (10)° with their adjacent 1H-benzimidazole groups. In the crystal, the mol-ecules are connected by N-H⋯N hydrogen bonds, forming separate C(4) chains of both the A and B mol-ecules along [010]. The A and B chains are cross-linked by several C-H⋯O inter-actions involving the benzene rings and the sulfonyl groups, which lead to R(2) (1)(5) loops in the linkage of the chains.

| S-EPMC3393333 | biostudies-literature

catena-Poly[[(diiodidocadmium)-μ-{1-[(1H-benzimidazol-2-yl)meth-yl]-1H-imidazole-κN:N'}] N,N-dimethyl-formamide monosolvate].

Project description:In the title complex, {[CdI(2)(C(11)H(10)N(4))]·C(3)H(7)NO}(n), the Cd(II) ion is four-coordinated by two N atoms from two 1-[(1H-benzimidazol-1-yl)meth-yl]-1H-imidazole (bmi) ligands and by two terminal I(-) anions in a distorted tetra-hedral geometry. One of the two I(-) anions is disordered over two sets of sites, with refined occupancies of 0.66 (5) and 0.34 (5). The Cd(II) ions are bridged by bmi ligands, leading to the formation of a chain along [001]. Dimethyl-formamide solvent mol-ecules are located between these chains. Classical N-H⋯O hydrogen bonding between the bmi ligands and the solvent mol-ecules leads to a consolidation of the structure.

| S-EPMC3238781 | biostudies-literature

Dichloridobis[5-nitro-1-trimethyl-silyl-methyl-1H-benzimidazole-κN]cobalt(II) N,N-dimethyl-formamide solvate.

Project description:The title compound, [CoCl(2)(C(11)H(15)N(3)O(2)Si)(2)]·C(3)H(7)NO, was synthesized from 5-nitro-1-trimethyl-silylmethyl-1H-benzimid-azole and cobalt(II) chloride in dimethyl-formamide. The Co(II) atom is coordinated in a distorted tetra-hedral environment by two Cl atoms and two N atoms. In the crystal structure, there are a number of C-H⋯Cl and C-H⋯O hydrogen-bonding inter-actions between symmetry-related mol-ecules.

| S-EPMC2983604 | biostudies-literature

1,4-Bis(1H-benzimidazol-1-yl)benzene.

Project description:In the title compound, C(20)H(14)N(4), the dihedral angles between the central benzene ring and the pendant benzimidazole ring systems are 46.60 (15) and 47.89 (16)°. The dihedral angle between the benzimidazole ring systems is 85.62 (12)° and the N atoms lie to the same side of the mol-ecule. In the crystal, mol-ecules are linked by C-H⋯N inter-actions and weak aromatic π-π stacking [shortest centroid-centroid separation = 3.770 (2) Å] is observed.

| S-EPMC3200633 | biostudies-literature

2,2'-(Quinoxaline-2,3-di-yl)diphenol dimethyl-formamide solvate.

Project description:In the title compound, C(20)H(14)N(2)O(2)·C(3)H(7)NO, the quinoxaline ring forms dihedral angles of 64.9 (2) and 30.9 (2)° with the two substituted benzene rings, which are themselves inclined at 58.4 (2)°. An intra-molecular O-H⋯N hydrogen bond occurs. In the crystal, mol-ecules are linked through inter-molecular O-H⋯O hydrogen bonds.

| S-EPMC2979914 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data